78 related articles for article (PubMed ID: 10359889)
1. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
Deykin A; Wechsler ME; Boushey HA; Chinchilli VM; Kunselman SJ; Craig TJ; DiMango E; Fahy JV; Kraft M; Leone F; Lazarus SC; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
Am J Respir Crit Care Med; 2007 Feb; 175(3):228-34. PubMed ID: 16973987
[TBL] [Abstract][Full Text] [Related]
3. Long-acting bronchodilators: time for a re-think.
Vassiliou V; Zipitis CS
J R Soc Med; 2006 Aug; 99(8):382-3. PubMed ID: 16893927
[No Abstract] [Full Text] [Related]
4. Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol.
Palmer CN; Lipworth BJ; Lee S; Ismail T; Macgregor DF; Mukhopadhyay S
Thorax; 2006 Nov; 61(11):940-4. PubMed ID: 16772309
[TBL] [Abstract][Full Text] [Related]
5. Inhaled β-agonist does not modify sympathetic activity in patients with COPD.
Haarmann H; Mohrlang C; Tschiesner U; Rubin DB; Bornemann T; Rüter K; Bonev S; Raupach T; Hasenfuß G; Andreas S
BMC Pulm Med; 2015 Apr; 15():46. PubMed ID: 25924990
[TBL] [Abstract][Full Text] [Related]
6. Dyspnoea worsened by salmeterol.
Fraser J
J R Soc Med; 2002 Nov; 95(11):558-9. PubMed ID: 12411626
[No Abstract] [Full Text] [Related]
7. The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol.
Perkins GD; Park D; Alderson D; Cooke MW; Gao F; Gates S; Lamb SE; Mistry D; Thickett DR
Trials; 2011 Mar; 12():79. PubMed ID: 21406094
[TBL] [Abstract][Full Text] [Related]
8. ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
Tcheurekdjian H; Via M; De Giacomo A; Corvol H; Eng C; Thyne S; Chapela R; Rodriguez-Cintron W; Rodriguez-Santana JR; Avila PC; Burchard EG;
J Allergy Clin Immunol; 2010 Oct; 126(4):853-8. PubMed ID: 20810156
[TBL] [Abstract][Full Text] [Related]
9. Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases.
Moosavi SA; Raji H; Tasorian B; Mostafapour E; Shahabi S; Purfakharan M; Fereshtehnejad SM
Med J Islam Repub Iran; 2013 May; 27(2):57-61. PubMed ID: 23741166
[TBL] [Abstract][Full Text] [Related]
10. Role of interactions in pharmacogenetic studies: leukotrienes in asthma.
Via M; Tcheurekdjian H; González Burchard E
Pharmacogenomics; 2013 Jun; 14(8):923-9. PubMed ID: 23746186
[TBL] [Abstract][Full Text] [Related]
11. Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist.
Bandaru S; Marri VK; Kasera P; Kovuri P; Girdhar A; Mittal DR; Ikram S; Gv R; Nayarisseri A
Bioinformation; 2014; 10(10):652-7. PubMed ID: 25489175
[TBL] [Abstract][Full Text] [Related]
12. G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.
Wendell SG; Fan H; Zhang C
Pharmacol Rev; 2020 Jan; 72(1):1-49. PubMed ID: 31767622
[TBL] [Abstract][Full Text] [Related]
13. Does zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysis.
Chen CF; Lv Y; Zhang HP; Wang G
Multidiscip Respir Med; 2014; 9(1):30. PubMed ID: 24936302
[TBL] [Abstract][Full Text] [Related]
14. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
[TBL] [Abstract][Full Text] [Related]
15. Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma.
Stanford RH; Shah M; D'Souza AO
J Asthma Allergy; 2013; 6():1-10. PubMed ID: 23300347
[TBL] [Abstract][Full Text] [Related]
16. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2012 May; 2012(5):CD002314. PubMed ID: 22592685
[TBL] [Abstract][Full Text] [Related]
17. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
[TBL] [Abstract][Full Text] [Related]
18. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
[TBL] [Abstract][Full Text] [Related]
19. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005307. PubMed ID: 19821344
[TBL] [Abstract][Full Text] [Related]
20. Regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Cates MJ
Cochrane Database Syst Rev; 2008 Jul; (3):CD006363. PubMed ID: 18646149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
